Liberty Health buys 387 acres to become a leading Florida producer

Toronto-based Liberty Health Sciences Inc. (CSE:LHS) (OTC:LHSIF) announced it will acquire all of the outstanding shares of its wholly-owned subsidiary, 242 Cannabis, LLC, including 387 acres in Gainesville, Florida previously owned by Alico Citrus Nursery, LLC.

The property includes over 200,000 sf of greenhouses, head houses, tissue culture lab and processing facilities. Liberty plans to retrofit the facilities to include a 16,000 sf processing area for extraction and refining of cannabis oils.

Upon completion, Liberty will be one of the largest medical cannabis providers in Florida with an expected annual capacity of 12,000 kg. The retrofitted facilities will let Liberty expand production a year sooner than projected, to meet the growing patient demand in Florida.

The stock was up 13% yesterday on the news to $1.760.

The facility will produce vaporizer products including preloaded disposable pens, cartridges and pods. It will also have a commercial kitchen to produce edibles and chewable dosage forms, once the state has defined the regulations. Liberty will continue to offer capsules, oral solutions (tinctures) and topicals.

To pay for the deal, Liberty will issue 18,815,322 units, each comprising one common share at $1.6476 and one-half common share purchase warrant, exercisable at $2.07 per share for three years. The Company said the deal to close on or prior to February 9, 2018,

Liberty said the previously announced bought deal equity financing has been mutually terminated with the underwriters, Clarus Securities Inc. and AltaCorp. Capital Inc.

Source Liberty Health press release

Liberty Health buys 387 acres to become a leading Florida producer

Cannin Investment Group: Your Hemp Stocks Experts

Cannin.com is your trusted resource for hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2020.

Use Cannin as your resource for:

Is it too late to invest in hemp stocks? No! This is the perfect time to invest.

Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now.

Are you interested in hemp stocks like GW Pharmaceuticals, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Are you looking to buy stock in hemp companies or marijuana companies in 2020? Interested in emerging penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks to invest in? We can help.

Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

+25% Gains in 2020
+49.8% Gains in 2019
Backtested since 2012

At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best hemp stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks

Liberty Health buys 387 acres to become a leading Florida producer